Home/EVOQ Therapeutics/Greg Barrett
GB

Greg Barrett

Communications/Executive (inferred from bylines)

EVOQ Therapeutics

EVOQ Therapeutics Pipeline

DrugIndicationPhase
NanoDisc Platform ProgramsAutoimmune Diseases (Type 1 Diabetes, Celiac, Lupus, MS)Preclinical